New England Healthcare Institute

New England Healthcare Institute
Name	New England Healthcare Institute
Type	Nonprofit research organization
Founded	2002
Defunct	2014
Location	Boston, Massachusetts
Region served	New England
Focus	Healthcare research, policy analysis

New England Healthcare Institute was an independent, nonprofit research organization based in Boston, Massachusetts that operated from 2002 to 2014. It conducted applied research and policy analysis on healthcare delivery, innovation, and cost trends affecting stakeholders across Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont. The institute brought together leaders from academic medicine, biotechnology, pharmaceutical industry, hospital systems, and health insurance to inform decision-making in regional and national arenas such as Health Affairs, Centers for Medicare & Medicaid Services, and state legislatures.

History

The institute was founded in 2002 by executives and faculty affiliated with institutions like Partners HealthCare, Massachusetts General Hospital, and Tufts Medical Center to address rising healthcare costs and quality concerns highlighted by reports from Institute of Medicine and initiatives such as Medicare reform debates. Early projects paralleled efforts by Commonwealth Fund, Robert Wood Johnson Foundation, and advocacy in Massachusetts health care reform debates associated with then‑Governor Mitt Romney and later state policymakers. Over its existence the organization published analyses that intersected with work at Harvard Medical School, Yale School of Medicine, Dartmouth Medical School, and Brown University School of Medicine and engaged with federal actors including Agency for Healthcare Research and Quality.

Mission and Activities

The institute's stated mission was to improve the value of healthcare by producing evidence for stakeholders including healthcare providers, life sciences firms, fiscal authorities like State Treasurer of Massachusetts, and patient advocacy groups such as AARP. Activities included convening CEO roundtables with leaders from Blue Cross Blue Shield of Massachusetts, Vertex Pharmaceuticals, and Biogen Idec; running policy forums with representatives from Massachusetts Department of Public Health and Connecticut Department of Public Health; and collaborating on implementation pilots with systems like Beth Israel Deaconess Medical Center and St. Francis Hospital. The institute emphasized translational projects aligned with efforts by National Institutes of Health, Food and Drug Administration, and the Office of the Assistant Secretary for Planning and Evaluation.

Research and Publications

Research programs produced reports on topics such as comparative effectiveness, readmissions, workforce supply, and health information technology—areas also studied by RAND Corporation, Brookings Institution, and Kaiser Family Foundation. Publications included white papers, policy briefs, and case studies drawing on datasets from Centers for Disease Control and Prevention surveillance, CMS Hospital Compare, and state hospital discharge databases. Notable reports examined post‑acute care patterns near networks like Lahey Clinic, prescription drug utilization relevant to Pfizer and Merck, and regional innovation ecosystems tied to Massachusetts Biotechnology Council. The institute's outputs were cited by entities including Commonwealth Fund, National Academy of Medicine, and state legislative committees.

Policy and Advocacy

While primarily research‑oriented, the institute engaged in policy discussions alongside organizations such as National Governors Association, American Hospital Association, and American Medical Association. It provided testimony to state legislatures during deliberations on hospital payment reform and certificate‑of‑need statutes, participating in task forces with representatives from Massachusetts Health Policy Commission and Rhode Island Office of Health and Human Services. The institute’s analyses informed debates related to payment models promoted by Medicare Shared Savings Program and state efforts echoing concepts from Accountable Care Organization demonstrations.

Partnerships and Collaborations

The institute partnered with academic centers including Harvard School of Public Health, Yale School of Public Health, Dartmouth Institute for Health Policy and Clinical Practice, and University of Connecticut School of Medicine. It collaborated with industry partners such as Johnson & Johnson, Eli Lilly and Company, and regional systems like UMass Memorial Health Care. Multistakeholder coalitions involved groups like National Quality Forum, Leapfrog Group, and patient organizations including American Cancer Society and regional chapters of American Heart Association.

Organizational Structure and Funding

Governance included a board composed of executives from Beth Israel Lahey Health, Massachusetts General Physicians Organization, and representatives from universities such as Brown University and Bates College alumni engaged in philanthropy. Funding derived from foundations like Robert Wood Johnson Foundation, Commonwealth Foundation, and corporate sponsors from biotechnology industry and health insurers including Blue Cross Blue Shield Association. Research grants complemented fee‑for‑service contracts with state agencies and healthcare systems; contracting mechanisms mirrored those used by RAND Corporation and Abt Associates.

Impact and Criticism

The institute influenced regional policy discussions on cost containment, readmissions, and health IT adoption, with impact noted in reforms similar to initiatives by Massachusetts Health Connector and analyses used by CMS Innovation Center. Critics and watchdogs from outlets like ProPublica and commentators associated with Cato Institute questioned potential conflicts of interest arising from industry funding, echoing concerns raised about policymaking ties in reports by The New York Times and The Boston Globe. Academic critics compared its role to that of think tanks such as Heritage Foundation and Urban Institute when debating independence and transparency.

Category:Healthcare research organizations Category:Non-profit organizations based in Boston